Acute on CKD
Reading File
Finding Sources
Finding Sources
Searching PubMed
"acute on chronic kidney disease" OR "AKI on CKD"
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
"acute kidney injury" AND "chronic kidney disease" AND outcomes
Good - I have all the core content needed. Let me now compile the comprehensive answer.
Acute-on-Chronic Kidney Disease (Acute-on-CKD)
Definition
Acute-on-chronic kidney disease (also called AKI on CKD) refers to an episode of acute kidney injury (AKI) superimposed on pre-existing chronic kidney disease (CKD). The patient has a reduced baseline GFR and then suffers an additional, abrupt further decline. Both the KDIGO AKI criteria and the CKD staging framework apply simultaneously.
- Brenner and Rector's The Kidney defines AKI as "a rapid (hours to days) decline in GFR resulting in retention of metabolic waste products" - and explicitly states it can develop de novo in intact kidneys or be superimposed on underlying CKD (acute on chronic kidney injury).
- Comprehensive Clinical Nephrology, 7th Ed. notes that among inpatients, prerenal azotemia and acute tubular injury (ATI) account for most AKI, "often in the setting of AKI superimposed on chronic kidney disease (CKD), so-called acute-on-chronic kidney disease."
Why CKD Is the Most Important Risk Factor for AKI
The presence of underlying CKD is one of the most important risk factors for developing AKI. Multiple mechanisms drive this susceptibility:
| Mechanism | Consequence |
|---|---|
| Diminished renal functional reserve | Less buffer before GFR drops to dangerous levels |
| Impaired salt and water conservation | Predisposition to intravascular volume contraction |
| Decreased detoxification mechanisms | Greater susceptibility to cytotoxic/nephrotoxic injury |
| Impaired clearance of nephrotoxins | Prolonged exposure duration |
| Macrovascular and microvascular disease | Increased risk of ischemic injury |
Causes (Precipitants of the Acute Episode)
The same pre-renal/intrinsic/post-renal framework applies, but CKD patients are especially vulnerable to:
Pre-renal (most common):
- Volume depletion: vomiting, diarrhea, over-diuresis, hemorrhage
- Reduced cardiac output: heart failure, cardiogenic shock
- Sepsis (systemic vasodilation + renal vasoconstriction)
- Drugs: NSAIDs (block afferent vasodilation), ACE inhibitors/ARBs (block efferent vasoconstriction), calcineurin inhibitors
Intrinsic renal:
- Acute tubular injury (ATI/ATN): ischemic or nephrotoxic (aminoglycosides, iodinated contrast, cisplatin, myoglobin)
- Acute interstitial nephritis (drugs, infections)
- Rapidly progressive glomerulonephritis superimposed on CKD
- Thrombotic microangiopathy, vasculitis
- Atheroembolic renal disease ("flash pulmonary edema" + acute-on-CKD is a hallmark presentation of atheromatous renal artery stenosis - Comprehensive Clinical Nephrology, 7th Ed.)
Post-renal:
- Urinary tract obstruction (BPH, stones, malignancy) - especially dangerous in solitary or transplant kidneys
Diagnosis
Step 1: Establish Baseline Creatinine
The key diagnostic challenge is distinguishing acute from chronic from acute-on-chronic. This requires knowing the prior baseline creatinine. In the absence of prior values:
- Chronicity markers: small shrunken kidneys on imaging, anaemia, renal osteodystrophy, neuropathy
- Absence of chronicity markers favours acute
Step 2: Apply KDIGO AKI Criteria (RIFLE/AKIN/KDIGO)
| Stage | Serum Creatinine Criteria | Urine Output Criteria |
|---|---|---|
| 1 | Rise ≥0.3 mg/dL within 48h OR ×1.5-1.9 from baseline | <0.5 mL/kg/h for 6-12h |
| 2 | ×2.0-2.9 from baseline | <0.5 mL/kg/h for ≥12h |
| 3 | ×3.0 from baseline OR ≥4.0 mg/dL OR RRT initiated | <0.3 mL/kg/h for ≥24h or anuria ≥12h |
Step 3: Urine Characterisation
- Pre-renal: FENa <1% (but may be <1% in contrast nephropathy, early obstruction), urine osmolality >500 mOsm/kg, urine Na <20 mmol/L
- ATI: FENa >2%, granular/muddy brown casts, RTE cell casts, urine osmolality ~300 mOsm/kg (isosthenuric)
- Glomerulonephritis: dysmorphic RBCs, RBC casts, heavy proteinuria
- Obstruction: may have variable findings; ultrasound is key
Step 4: Renal Ultrasound
- Mandatory - assess for obstruction (hydronephrosis)
- Small echogenic kidneys confirm chronicity
- Doppler for renal vascular assessment if renovascular disease suspected
Management
1. Identify and Reverse the Precipitant
This is the single most important step. Halt nephrotoxins (NSAIDs, aminoglycosides, contrast, ACE-i/ARBs in hypovolemia), treat sepsis aggressively, relieve obstruction.
2. Volume Management
- Restore euvolemia carefully - CKD patients have a narrow therapeutic window. Both hypovolemia (worsens AKI) and hypervolemia (pulmonary oedema, worsening CKD) are dangerous.
- Isotonic crystalloids (normal saline or balanced solutions) are preferred for resuscitation.
- Avoid hypotonic fluids.
3. Electrolyte and Acid-Base Management
CKD patients have less reserve, so AKI causes:
- Hyperkalaemia - restrict dietary K+, avoid K+-sparing drugs; severe hyperkalaemia requires calcium gluconate, insulin/dextrose, sodium bicarbonate, salbutamol, kayexalate/patiromer; dialysis if refractory
- Metabolic acidosis - correct with bicarbonate (cautiously, avoid pulmonary oedema)
- Hyperphosphataemia - phosphate binders
- Hyponatraemia - usually dilutional; treat underlying cause
4. Blood Pressure Control
- Target BP <130/80 mmHg (or as per CKD guidelines)
- Renin-angiotensin blockade may need temporary withdrawal during the acute phase if hyperkalaemia or haemodynamic instability
5. Drug Dose Adjustment
- Reduce or hold renally cleared drugs (metformin, low-molecular-weight heparin, antibiotics, digoxin)
- Monitor drug levels carefully
6. Nutrition
- Adequate caloric intake; protein restriction is NOT recommended during acute phase - aim 0.8-1.2 g/kg/day
- Avoid excessive protein loading
7. Renal Replacement Therapy (RRT)
Indications (the "AEIOU" criteria):
- Acidosis - refractory metabolic acidosis (pH <7.1)
- Electrolytes - refractory hyperkalaemia (K+ >6.5 mEq/L)
- Intoxication - dialysable toxins
- Overload - pulmonary oedema refractory to diuretics
- Uraemia - symptomatic (encephalopathy, pericarditis, bleeding)
In CKD patients already near the dialysis threshold, the AKI may serve as the final trigger for initiation of permanent renal replacement (HD/PD).
Prognosis
Acute-on-CKD carries significantly worse outcomes than AKI in previously normal kidneys:
| Outcome | AKI Alone | AKI on CKD |
|---|---|---|
| Non-recovery of renal function | Lower | Much higher |
| Progression to ESRD | Lower | Substantially higher |
| In-hospital mortality | Lower | Higher |
| CKD progression post-AKI | Slower | Faster (accelerated GFR decline) |
- A 2025 systematic review and meta-analysis (Veltkamp et al., Nephrol Dial Transplant, PMID 40424522) confirmed significantly elevated long-term adverse kidney outcomes after AKI episodes.
- Brenner and Rector's The Kidney cites: "Nonrecovery of kidney function and death after acute on chronic renal failure" as a key outcome marker, and notes underlying CKD is "one of the most important risk factors for the development of AKI."
Factors predicting non-recovery:
- Severity of AKI (Stage 3 > Stage 2 > Stage 1)
- Pre-existing GFD <30 mL/min (CKD Stage 3b or worse)
- Diabetes, hypertension, proteinuria
- Older age
- Delay in recognition and treatment
- Oliguria persisting >72h
- Need for dialysis
Summary Table
| Feature | Detail |
|---|---|
| Definition | AKI (abrupt GFR fall) superimposed on pre-existing CKD |
| Common precipitants | Volume depletion, sepsis, nephrotoxins, obstruction, NSAID/ACEi/contrast use |
| Key workup | Baseline creatinine review, KDIGO staging, urine microscopy, FENa, renal ultrasound |
| Management priorities | Remove precipitant, careful volume repletion, electrolyte correction, hold nephrotoxins |
| RRT trigger | Refractory acidosis, K+, fluid overload, or uraemia (AEIOU) |
| Prognosis | Worse than AKI alone; higher ESRD risk, mortality, and CKD progression rate |
| Follow-up | 3-month reassessment of GFR, proteinuria; nephrology referral if no recovery |
Sources: Comprehensive Clinical Nephrology, 7th Edition - Chapter 70 (Pathophysiology and Etiology of AKI) | Brenner and Rector's The Kidney, 2-Volume Set - Chapter 29 (Definition of AKI)
This is a shared conversation. Sign in to Orris to start your own chat.